HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Albanesi Selected Research

interferon kappa

3/2006Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis.
11/2002Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Albanesi Research Topics

Disease

24Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 07/2002
9Inflammation (Inflammations)
02/2022 - 11/2002
6Atopic Dermatitis (Atopic Eczema)
02/2022 - 07/2002
6Skin Diseases (Skin Disease)
07/2019 - 01/2002
5Allergic Contact Dermatitis
10/2010 - 01/2002
4Infections
09/2020 - 07/2007
3Neoplasms (Cancer)
07/2017 - 03/2015
2Virus Diseases (Viral Diseases)
09/2020 - 03/2006
1Dehydration (Water Stress)
02/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Arthritis (Polyarthritis)
06/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2021
1Autoimmune Diseases (Autoimmune Disease)
09/2020
1Hidradenitis Suppurativa
01/2020
1Pathologic Neovascularization
07/2019
1Skin Abnormalities
12/2017
1Melanoma (Melanoma, Malignant)
04/2017
1Pneumonia (Pneumonitis)
01/2016
1Fibrosis (Cirrhosis)
01/2016
1Cicatrix (Scar)
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015
1Basal Cell Carcinoma (Rodent Ulcer)
03/2015
1Skin Neoplasms (Skin Cancer)
03/2015
1Dermatitis
01/2014
1Crohn Disease (Crohn's Disease)
02/2011
1Hypersensitivity (Allergy)
05/2010
1Contact Dermatitis (Eczema, Contact)
05/2010
1Lichen Planus (Lichen Ruber Planus)
03/2006
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2002
1Pyoderma Gangrenosum
11/2002
1Behcet Syndrome (Behcet's Syndrome)
11/2002

Drug/Important Bio-Agent (IBA)

10CytokinesIBA
02/2022 - 07/2007
8Interleukin-22 (IL-22)IBA
10/2021 - 03/2011
5ChemokinesIBA
06/2021 - 01/2002
5Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2009
2Biological ProductsIBA
01/2022 - 01/2020
2Imiquimod (Aldara)FDA LinkGeneric
10/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
2NickelIBA
01/2014 - 06/2002
2HaptensIBA
05/2010 - 06/2002
2interferon kappaIBA
03/2006 - 11/2002
1Biomarkers (Surrogate Marker)IBA
02/2022
1Filaggrin ProteinsIBA
02/2022
1AntigensIBA
02/2022
1NucleophosminIBA
01/2022
1NF-kappa B (NF-kB)IBA
01/2022
1seletalisibIBA
10/2021
1NAD (NADH)IBA
06/2021
1HLA-C Antigens (HLA-C)IBA
01/2021
1HLA-C*06 antigenIBA
01/2021
1secukinumabIBA
01/2021
1AutoantigensIBA
09/2020
1InterferonsIBA
09/2020
1DNA (Deoxyribonucleic Acid)IBA
09/2020
1Antimicrobial PeptidesIBA
09/2020
1CathelicidinsIBA
09/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2020
1Insulin-Like Growth Factor Binding Protein 2IBA
01/2020
1InterleukinsIBA
01/2020
1Adalimumab (Humira)FDA Link
01/2020
1Janus KinasesIBA
01/2018
1tofacitinibIBA
01/2018
1Janus Kinase InhibitorsIBA
01/2018
1Transcription Factors (Transcription Factor)IBA
12/2017
1Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA
12/2017
1Interleukin-10 (Interleukin 10)IBA
07/2017
1Peptides (Polypeptides)IBA
04/2017
1Adenosine Triphosphate (ATP)IBA
01/2016
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2016
1Adenine NucleotidesIBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
03/2015
1Interleukin-8 (Interleukin 8)IBA
03/2015
1Oxidants (Oxidizing Agents)IBA
01/2014
1PS 5 (PS-5)IBA
07/2013
1Sirtuin 1IBA
03/2011
1sirtinolIBA
01/2011
1SirtuinsIBA
01/2011
1Messenger RNA (mRNA)IBA
08/2010
1EnzymesIBA
04/2010
1Interferon Type IIBA
01/2009
1AllergensIBA
01/2009
1beta-DefensinsIBA
07/2007
1Double-Stranded RNA (RNA, Double Stranded)IBA
03/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2002
16-sulfo sialyl Lewis XIBA
06/2002
1Chemokine ReceptorsIBA
01/2002

Therapy/Procedure

3Therapeutics
01/2020 - 11/2002
2Immunomodulation
01/2020 - 01/2018